Gataparsen
Gataparsen is an antisense oligonucleotide directed against survivin mRNA with potential antitumor activity.
Product Specifications
CAS Number
1065019-70-6
Product Name Alternative
LY 2181308
UNSPSC
12352208
Target
Survivin
Related Pathways
Apoptosis
Field of Research
Cancer
Smiles
[Gataparsen]
References & Citations
[1]Wiechno P, Somer BG, Mellado B, et al. A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer. Eur Urol. 2014;65 (3) :516-520.|[2]Tanioka M, Nokihara H, Yamamoto N, et al. Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2011;68 (2) :505-511.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![FITC Rat IgG1, κ Isotype Control[HRPN]](https://cdn.genprice.uk/products/763/68dd1497061270361e7ce0c0/imageurl/e-ab-f09823c.webp)